Publicaciones en las que colabora con José Palacios Calvo (21)

2022

  1. Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases

    Cancers, Vol. 14, Núm. 5

  2. Progression to lung fibrosis in severe COVID-19 patients: A morphological and transcriptomic study in postmortem samples

    Frontiers in Medicine, Vol. 9

  3. RNA SARS-CoV-2 Persistence in the Lung of Severe COVID-19 Patients: A Case Series of Autopsies

    Frontiers in Microbiology, Vol. 13

2021

  1. Tumor mutational burden assessment in non-small-cell lung cancer samples: Results from the TMB 2 harmonization project comparing three NGS panels

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5

2019

  1. Clinical challenges and implications of intratumor heterogeneity

    Revista Espanola de Patologia, Vol. 52, Núm. 4, pp. 234-241

2017

  1. Treating KRAS -mutant NSCLC: Latest evidence and clinical consequences

    Therapeutic Advances in Medical Oncology, Vol. 9, Núm. 9, pp. 589-597

2013

  1. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: Implications for outcomes and histologic classification

    Carcinogenesis, Vol. 34, Núm. 5, pp. 1031-1038

  2. Fe de errores a «Recomendaciones para la determinación de mutaciones de K-RAS en cáncer de colon»

    Revista Espanola de Patologia

2012

  1. Recomendaciones para la determinación de mutaciones de K-RAS en cáncer de colon

    Revista Espanola de Patologia

2011

  1. Consenso de la Sociedad Española de Anatomía Patológica (SEAP) y de la Sociedad Española de Oncología Médica (SEOM) sobre la determinación de HER2 en el carcinoma gástrico

    Revista Espanola de Patologia, Vol. 44, Núm. 1, pp. 32-48

  2. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 636-651

2009

  1. Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia, Vol. 42, Núm. 1, pp. 3-16

  2. Guidelines for HER2 testing in breast cancer: A national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 11, Núm. 6, pp. 363-375

2007

  1. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis

    Cancer Research, Vol. 67, Núm. 7, pp. 3450-3460

  2. Sox2: A possible driver of the basal-like phenotype in sporadic breast cancer

    Modern Pathology, Vol. 20, Núm. 4, pp. 474-481

  3. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: An immunohistochemical and gene amplification study

    American Journal of Surgical Pathology, Vol. 31, Núm. 4, pp. 501-508

1992

  1. Anencephaly and limb deficiencies

    American Journal of Medical Genetics, Vol. 44, Núm. 1, pp. 66-71

  2. Tetra-phocomelia with multiple malformations: X-linked amelia, or Roberts syndrome, or DK-phocomelia syndrome? [3]

    American Journal of Medical Genetics

1988

  1. Malignant rhabdoid tumor of the tongue. A case report with immunohistochemical and ultrastructural findings

    Oral Surgery, Oral Medicine, Oral Pathology, Vol. 65, Núm. 1, pp. 67-70

1987

  1. Congenital oral juvenile xanthogranuloma: Report of a case

    Journal of Oral and Maxillofacial Surgery, Vol. 45, Núm. 8, pp. 707-709